Incidence and progression of cervical lesions in women with HIV: A systematic global review

International Journal of STD and AIDS

Volumn 25, Issue 3, 2014, Pages 163-177

  Denslow, Sheri A ^a   Rositch, Anne F ^b   Firnhaber, Cynthia ^c,d   Ting, Jie ^a   Smith, Jennifer S ^a,e  

^a IL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d RIGHT TO CARE   (South Africa)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

AIDS; cervical cancer; cervical lesions; CIN; HIV; incidence; progression; review; screening; SIL; squamous epithelial lesions; women

Indexed keywords

AIDS; CERVICAL CANCER; CERVICAL LESIONS; CIN; HIV; INCIDENCE; PROGRESSION; REVIEW; SCREENING; SIL; SQUAMOUS EPITHELIAL LESIONS; WOMEN;

ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; PRECANCEROUS CONDITIONS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84893950334     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462413491735     Document Type: Review

References (49)

1. UNAIDS, WHO. AIDS Epidemic Update: December 2009, http://data.unaids.org/pub/report/2009/jc1700_epi_update_2009_en.pdf (accessed March 1 2012).
2. Scheurer ME,Tortolero-Luna G.Human papillomavirus infection: biology, epidemiology, and prevention.Int J Gynecol Cancer. 2005;15:727-746.
3. De Vuyst H,Lillo F,Broutet N, et al.HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy.Eur J Cancer Prev. 2008;17:545-54.
4. Firnhaber C,Zungu K,Levin S, et al.Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa.Acta Cytol. 2009;53:10-17.
5. Ahdieh L,Munoz A,Vlahov D, et al.Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and - seronegative women.Am J Epidemiol. 2000;151:1148-1157.
6. Sun XW,Kuhn L,Ellerbrock TV, et al.Human papillomavirus infection in women infected with the human immunodeficiency virus.N Engl J Med. 1997;337:1343-1349.
7. Delmas MC,Larsen C,van Benthem B, et al.Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression.European Study Group on Natural History of HIV Infection in Women. AIDS. 2000;14:1775-1784.
8. Maiman M,Fruchter RG,Sedlis A, et al.Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus.Gynecol Oncol. 1998;68:233-239.
9. Olaitan A,Mocroft A,McCarthy K, et al.Cervical abnormality and sexually transmitted disease screening in human immunodeficiency virus-positive women.Obstet Gynecol. 1997;89:71-75.
10. Six C,Heard I,Bergeron C, et al.Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women.AIDS. 1998;12:1047-1056.
11. Wright TC,Ellerbrock TV,Chiasson MA, et al.Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study.Obstet Gynecol. 1994;84:591-597.
12. Massad LS,Riester KA,Anastos KM, et al.Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group.J Acquir Immune Defic Syndr. 1999;21:33-41.
13. Firnhaber C,Van Le H,Pettifor A, et al.Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa.Cancer Causes Control. 2009;21:433-443.
14. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.MMWR. 1992;41:1-19.
15. United States Department of State. Pink Ribbon Red Ribbon Overview and Press Release. 2011, www.state.gov/r/pa//prs/ps/2011/09/172244.htm. (accessed March 15 2012).
16. La Ruche G,Ramon R,Mensah-Ado I, et al.Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group.Cancer. 1998;82:2401-2408.
17. Branca M,Garbuglia AR,Benedetto A, et al.Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.Int J STD AIDS. 2003;14:417-425.
18. Heard I,Bergeron C,Jeannel D, et al.Papanicolaou smears in human immunodeficiency virus-seropositive women during follow-up.Obstet Gynecol. 1995;86:749-753.
19. Lehtovirta P,Finne P,Nieminen P, et al.Prevalence and risk factors of squamous intraepithelial lesions of the cervix among HIV-infected women - a long-term follow-up study in a low-prevalence population.Int J STD AIDS. 2006;17:831-834.
20. Petry KU,Bohmer G,Iftner T, et al.Human papillomavirus testing in primary screening for cervical cancer of human immunodeficiency virus-infected women, 1990-1998.Gynecol Oncol. 1999;75:427-431.
21. Sirera G,Videla S,Lopez-Blazquez R, et al.Evolution of cervical cytologic changes among HIV-infected women with normal cytology in the HAART era.AIDS Res Hum Retroviruses. 2007;23:965-971.
22. Soncini E,Zoncada A,Condemi V, et al.Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy.Acta Biomed. 2007;78:36-40.
23. Kitchener H,Nelson L,Adams J, et al.Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women.Int J Cancer. 2007;121:2484-2491.
24. Ellerbrock TV,Chiasson MA,Bush TJ, et al.Incidence of cervical squamous intraepithelial lesions in HIV-infected women.JAMA. 2000;283:1031-1037.
25. Massad LS,Seaberg EC,Wright RL, et al.Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up.Obstet Gynecol. 2008;111:1388-1393.
26. Schuman P,Ohmit SE,Klein RS, et al.Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.J Infect Dis. 2003;188:128-136.
27. Hawes SE,Critchlow CW,Sow PS, et al.Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.J Natl Cancer Inst. 2006;98:100-109.
28. Omar T,Schwartz S,Hanrahan C, et al.Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort.AIDS. 2011;25:87-94.
29. Chalermchockcharoenkit A,Chayachinda C,Thamkhantho M, et al.Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study.BMC Infect Dis. 2011;11:8-8.
30. Sirera G,Videla S,Lopez-Blazquez R, et al.Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.J Antimicrob Chemother. 2008;61:191-194.
31. Minkoff H,Zhong Y,Burk RD, et al.Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women.J Infect Dis. 2010;201:681-690.
32. Duerr A,Paramsothy P,Jamieson DJ, et al.Effect of HIV infection on atypical squamous cells of undetermined significance.Clin Infect Dis. 2006;42:855-861.
33. Kirby TO,Allen ME,Alvarez RD, et al.High-risk human papillomavirus and cervical intraepithelial neoplasia at time of atypical squamous cells of undetermined significance cytologic results in a population with human immunodeficiency virus.J Low Genit Tract Dis. 2004;8:298-303.
34. Massad LS,Evans CT,Minkoff H, et al.Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus.Obstet Gynecol. 2004;104:1077-1085.
35. Robinson WR,Andersen J,Darragh TM, et al.Isotretinoin for low-grade cervical dysplasia in human immunodeficiency virus-infected women.Obstet Gynecol. 2002;99:777-784.
36. Nappi L,Carriero C,Bettocchi S, et al.Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women.Eur J Obstet Gynecol Reprod Biol. 2005;121:226-232.
37. Del Mistro A,Bertorelle R,Franzetti M, et al.Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women.Clin Infect Dis. 2004;38:737-742.
38. Calore EE,Manzione CR,Nadal SR, et al.Ki-67 expression in anal intraepithelial neoplasia in AIDS.Sao Paulo Med J. 2001;119:119-121.
39. La Ruche G,Leroy V,Mensah-Ado I, et al.Short-term follow up of cervical squamous intraepithelial lesions associated with HIV and human papillomavirus infections in Africa.Int J STD AIDS. 1999;10:363-368.
40. Firnhaber C,Westreich D,Schulze D, et al.Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa.J Int AIDS Soc. 2012;15:1-6.
41. Adler DH,Kakinami L,Modisenyane T, et al.Increased regression and decreased incidence of HPV-related cervical lesions among HIV-infected women on HAART.AIDS. 2012;26:1645-1652.
42. Clifford GM,Franceschi S.Cancer risk in HIV-infected persons: influence of CD4(+) count.Future Oncol. 2009;5:669-678.
43. Nicol AF,Fernandes AT,Bonecini-Almeida Mda G.Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection - review.Mem Inst Oswaldo Cruz. 2005;100:1-12.
44. Nicol AF,Pires AR,de Souza SR, et al.Cell-cycle and suppressor proteins expression in uterine cervix in HIV/HPV co-infection: comparative study by tissue micro-array (TMA).BMC Cancer. 2008;8:289-289.
45. Kim RH,Yochim JM,Kang MK, et al.HIV-1 Tat enhances replicative potential of human oral keratinocytes harboring HPV-16 genome.Int J Oncol. 2008;33:777-782.
46. Minkoff H,Ahdieh L,Massad LS, et al.The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.AIDS. 2001;15:2157-2164.
47. Paramsothy P,Jamieson DJ,Heilig CM, et al.The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.Obstet Gynecol. 2009;113:26-31.
48. Lillo F,Ferrari D,Veglia F, et al.Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.J Infect Dis. 2001;184:547-451.
49. Heard I,Tassie JM,Kazatchkine MD, et al.Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women.AIDS. 2002;16:1799-1802.